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Abstract
Background: Verrucous carcinoma of the vulva is extremely rare. It is a slow growing, low malignant variant of a
squamous cell carcinoma with a cauliflower appearance. Women with lichen planus have an increased risk of
developing vulval cancer.
Case presentation: A 79-year-old woman consulted for vulval itching. On clinical examination, a 3-cm large
verrucous clitoral cancer in an area of lichen planus was seen. Based on her last clinical examination, the growth
was estimated to be 1 cm2 per month with an invasion depth after 6 months of 5 mm. A tumor developing in an
area of lichen planus appears to have more aggressive features. This is the first time that the growth of a verrucous
carcinoma has been documented in an area of lichen planus.
Conclusions: Clinicians and patients should be aware of the aggressive behavior of cancers developing in areas of
lichen planus and adjust their surgical management together with the follow-up strategy.
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Background
Vulval cancer is a rare disease. It encompasses 0.58% of
all female cancers and 0.36% of all cancer deaths in
women [1]. Eighty to 90% of all primary vulval cancers
are of squamous origin. A verrucous carcinoma is a very
rare variant of a squamous carcinoma. It was described
for the first time in 1948 in the oral cavity [2]. Later on,
also other locations were described like the cervix,
vagina, bladder, penis, and scrotum [3].
A verrucous carcinoma is a distinct entity with an
exo- and endophytic growth pattern, minimal cell atypia,
and pushing margins in contrast to the invasive character
of well-differentiated squamous carcinoma [2]. Macro-
scopically, the tumor has an aggressive cauliflower
appearance, which can easily be confused with a
Buschke-Löwenstein tumor [4]. Microscopically on
the other hand it is a well-differentiated tumor with a
low malignant potential. To the best of our knowledge,
this is the first description of a verrucous carcinoma in an
area of lichen planus.
Case presentation
A 79-year-old woman consulted for vulval itching. Her
past medical history included a breast cancer 2 years
earlier. Her breast cancer was staged as pT1pN0M0 and
treated by surgery and adjuvant tamoxifen 20 mg daily.
On clinical examination, a pink vulva was seen with
on the right side a grey-white area (Fig. 1). A biopsy was
performed of this area and showed lichen planus. Due to
the intense itching, the grey-white area was removed.
She had a regular follow-up. She revisited the clinic
12 months later when the itching had recurred. The
itching started 6 months earlier. Initially it did not
bother her, but after a while she noted that a grey-white
area was growing on her clitoris.
On clinical examination, an exophytic cauliflower-like
mass of 3 cm in diameter was noted on the clitoris. The
mass extended to the labia minus on both sites. The
urethral meatus was free by a macroscopically margin of
5 mm. No groin nodes were palpated. On inspection,
there was no involvement of the vagina or the cervix.
Clinically, the mass had the appearance of a vulval cancer
or a wart (Fig. 2). Due to the location of the tumor and its
macroscopical features, it was opted to remove the tumor
with a margin of 1 cm instead of performing a biopsy first.
* Correspondence: Wiebren.Tjalma@uza.be
Department of Obstetrics and Gynecology, Multidisciplinary Breast Clinic,
Gynecological Oncology Unit, Antwerp University Hospital - University of
Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tjalma et al. World Journal of Surgical Oncology  (2017) 15:7 
DOI 10.1186/s12957-016-1069-0
Pathological examination showed an endophytic lesion
with hyper- and parakeratosis (blue arrow) with only
mild atypia (Figs. 3 and 4). The lesion invades deep into
the dermis in the form of bulbous ends with a pushing
border (yellow arrows) (Figs. 3 and 4). The tumor itself
is a highly differentiated tumor with only mild atypia
(Fig. 5). A characteristic feature is the infiltration of the
tumor nests through neutrophils (black arrows) (Fig. 5).
The adjacent epithelium shows features of lichen planus;
hyperkeratosis without parakeratosis (blue arrow),
hypergranulosis (yellow arrow), band-like inflammatory
infiltrate in the underlying dermis with invasion of
lymphocytes into the basal layer of the epithelium (black
arrow), vacuolation of basal keratinocytes and apoptotic
cells (green arrow) (Fig. 6). The HPV DNA assay re-
vealed that the tumor was HPV negative. The definitive
pathology showed a 2 × 3 cm well-differentiated verru-
cous carcinoma with tumor free margins. The margin to
the urethra was 7 mm and all other margins were more
than 1 cm. The maximum depth of infiltration was
5 mm.
Clinically, there rose a problem. Normally, the therapy
would stop here; these verrucous cancers are slow
growing and hardly metastasize. However, in our case,
the tumor developed with a growth of 1 cm2 per month
and had an infiltration depth of 5 mm after 6 months.
These features gave the tumor an “aggressive”-looking
behavior. For a verrucous carcinoma, no additional
surgery would be performed. For a classic squamous
carcinoma, one would perform a sentinel node biopsy
Fig. 1 A grey-white area of lichen planus on the right sight of the vulva
Fig. 2 An exophytic and cauliflower-looking mass centrally on
the clitoris
Fig. 3 An endophytic lesion with hyper- and parakeratosis (blue arrow).
There is no marked cytologic atypia. It invades deep into the dermis in
the form of bulbous ends with a pushing border (yellow arrows)
(hematoxylin-eosin staining, magnification ×40)
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and in case of a metastatic node a bilateral femoral
inguinal node resection. In the current case, due to the
aggressive features, there were three possible treatment
options: (1) no groin surgery; (2) the classical bilateral
inguinofemoral resection en bloc; (3) sentinel node
biopsy and only in case of an involved lymph node an en
bloc resection. Of course, there was always the possibil-
ity that due to the previous surgery no sentinel node
could be identified. Together with the patient and her
family (shared decision making), it was decided to per-
form a sentinel node procedure and if there were tumor
cells in the sentinel node, an en bloc resection of both
groins would be performed. In case no sentinel node
could be identified in both groins, no groin surgery
would be performed. In a second procedure, both sentinel
nodes were identified with technetium. The preoperative
examination of the nodes as well as the definitive results
showed no tumor involvement of the lymph nodes. The
tumor was staged as FIGO IB and no additional treatment
was advised. At present, 29 months after the diagnosis,
the patient is well with no signs of recurrence.
Discussion
Verrucous carcinoma of the clitoris is extremely rare
with only one previously described case in the literature
[5]. A HPV infection can be detected in about one third
of the cases [2, 3]. This seems consistent with the role of
HPV in the development of vulval cancer in general.
Vulval cancers can be divided in two groups. The first
group is the young patients with multicenter tumors as-
sociated with HPV infection, smoking, and precancerous
lesions (vulvar intraepithelial lesions (VIN)). The other
group is the older patients with HPV-negative tumors
associated with lichen sclerosus and squamous hyperpla-
sia [6]. It is estimated that about 5% of all VIN 3 lesions
will progress to an invasive disease [7] and almost 7% of
all squamous cancers of the vulva occur in an area of
lichen sclerosus [8]. In the current case, the verrucous
cancer developed in an area of lichen planus. In contrast
to squamous cell carcinoma, the development of a
verrucous carcinoma in cutaneous or oral lichen planus
is rare. The first association of vulvar lichen planus and
squamous cell cancer was reported in 1989 [9].
Lichen planus is a chronic inflammatory autoimmune
dermatosis. In oral and esophageal mucosa, lichen pla-
nus has a cancer risk of 5% [10]. In HPV-negative penile
cancer, lichen planus is recognized as a risk factor; but
in HPV negative vulval cancer, this is surprisingly not
the case [10–12]. HPV-negative squamous cell cancers
Fig. 5 A highly differentiated tumor without marked atypia is seen.
The cells resemble to normal epithelium. A characteristic feature is
the infiltration of the tumor nests through neutrophils (black arrows)
(hematoxylin-eosin staining, magnification ×40)
Fig. 6 The adjacent epithelium shows features of lichen planus;
hyperkeratosis without parakeratosis (blue arrow), hypergranulosis
(yellow arrow), band-like inflammatory infiltrate in the underlying
dermis with invasion into the basal layer of the epithelium
(black arrow), vacuolation of basal keratinocytes and apoptotic cells
(green arrow) (hematoxylin-eosin staining, magnification ×200)
Fig. 4 An endophytic lesion with hyper- and parakeratosis (blue arrow).
There is no marked cytologic atypia. It invades deep into the dermis in
the form of bulbous ends with a pushing border (yellow arrows)
(hematoxylin-eosin staining, magnification ×40)
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associated with lichen planus have been located in
the nonhair-bearing vulvar mucosa in 47% and in the
vestibulum in 53% [10]. In the present case, the
tumor was located on the clitoris at a microscopic
distance of 7 mm from the urethra.
For lichen sclerosus or lichen planus without carcinoma,
topical corticosteroids are the first choice. A second-line
treatment is tacrolimus ointment. In case of a squamous
carcinoma, surgery is the preferred option. An alternative
option for a patient with a squamous cell carcinoma in a
specific area can be photodynamic therapy.
The advised therapy however of a verrucous tumor is
a wide local excision with a 1-cm tumor-free margin.
Inadequate surgery will lead to an increased risk of
recurrences. Primary radiotherapy is contraindicated as
it has 11–30% risk of anaplastic transformation [2].
Verrucous carcinomas rarely metastasize to the inguino-
femoral lymph nodes. Lichen planus-associated squamous
carcinomas on the other hand are aggressive malignancies
with inguinal metastases in 42% and a local recurrence
after surgery of 39% [10]. Eighty-six percent of the recur-
rences occurred within 1 year and 37% died [10].
Verrucous carcinomas in general are regarded as slow
growing tumors with an indolent character. In the
current case and for the first time in literature, it was
documented that there was a growth of 1 cm2 per
month. In verrucous carcinoma, there is mostly only a
minimal invasion of the superficial layers. The invasion
depth in present case was 5 mm, and it was estimated
that the tumor invaded 0.8 mm per month. The speed of
the growth and the depth of the invasion are features of
aggressiveness. The aggressive behavior of a verrucous
carcinoma could be explained by the development of
the tumor in an area of lichen planus. The progres-
sion and prognosis of a verrucous squamous cell
carcinoma in the context of a lichen planus require
further investigations.
Verrucous carcinomas have a high risk of local recur-
rence (30%). It is likely that in our case the patient will
have a recurrence. The question is if you should call it a
recurrence or the development of a new cancer in an
area of lichen planus. Based on the fact that lichen
planus is a risk factor, you better call it the development
of a new cancer. Women with active lichen planus and
also lichen sclerosis should be regarded as at risk for
malignant transformation. A reduction in cancer pro-
gression could theoretically be induced by the treatment
of active lichen planus or lichen sclerosis. A recent
randomized controlled trial demonstrated improvements
in the disease course of lichen planus with initial aggres-
sive therapy involving oral prednisolone, with or without
additional topical corticosteroids application, and main-
tenance therapy with weekly low-dose methotrexate
when topical therapy was not adequate [13, 14]. The use
of immunosuppressive agent is also often mentioned in
the literature; however, they bear the risk of increased
malignant transformation.
Conclusions
Lichen planus has a chronic nature and there is often a
delay in diagnosis of a verrucous cancer of several
months. A verrucous carcinoma developing in an area of
lichen planus has more aggressive features. Women
should be informed or rather educated about the risk of
malignant transformation in case of active lichen planus.
If there are complaints, patients should use a topical
corticosteroid. If there is no improvement within 5 days,
they should contact their physician. Physicians should
also be aware of the malignant potential of lichen planus
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